AI assistant
Sending…
RESMED INC — Director's Dealing 2025
Nov 13, 2025
30071_dirs_2025-11-13_3abd52cd-d127-4e10-bc92-e5ca5d8764e0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-11-11
Reporting Person: FARRELL PETER C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-11 | ResMed Common Stock | F | 162.953 | $250.10 | Disposed | 68110 | Direct |
| 2025-11-12 | ResMed Common Stock | S | 2000 | $252.05 | Disposed | 66110 | Direct |
Footnotes
F1: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2024.
F2: The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29